Recent evidence has demonstrated that endothelial-specific growth factors affect the development of apparently unrelated organs and cells. Expanding this evidence further, new findings in this issue of the JCI show that neurotrophic factors can affect neovascularization. Neurotrophic factors achieve proangiogenic effects not only by directly affecting endothelial cells, but also by recruiting hematopoietic precursors. Further understanding of the biology of angiogenic factors, as well as of the function of hematopoietic cells in tissue neovascularization, will lead to improved therapeutic strategies for the treatment of diseases ranging from ischemia to cancer.
Dan G. Duda, Rakesh K. Jain
Title and authors | Publication | Year |
---|---|---|
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
P Papanagnou, T Stivarou, M Tsironi |
Pharmaceuticals (Basel, Switzerland) | 2016 |
Neuronal and astrocytic interactions modulate brain endothelial properties during metabolic stresses of in vitro cerebral ischemia
G Chaitanya, A Minagar, JS Alexander |
Cell Communication and Signaling | 2014 |
Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy
X Liu, Y Li, Y Liu, Y Luo, D Wang, BH Annex, PJ Goldschmidt-Clermont |
The American Journal of Pathology | 2010 |
Features of cardiomyocyte proliferation and its potential for cardiac regeneration
MJ van Amerongen, FB Engel |
Journal of Cellular and Molecular Medicine | 2008 |